Animated Explainer Videos
REPROCELL Webinars

Customized Central Laboratory Services for Support of Global Clinical Trials: PBMC Processing
Dr Nikola Kolundzic
Study Director, REPROCELL Europe, UK

Working with Mature, Chamber-Specific Cardiomyocytes
Dr Travis Block
Chief Technology Officer, StemBioSys

Human Tissue in Drug Discovery Scientific, Technical & Regulatory Perspective
David Bunton
CEO REPROCELL Europe (founder of Biopta Ltd. now part of REPROCELL) UK

Clinically compatible advances in blood-derived EPC isolation and reprogramming
Dr Amer Rana
Director of Biomedical Research Center, University of East Anglia, UK

Enabling translational research through access to high quality biospecimens
Dr. Rachna Goyal
Manager, Preclinical Genomics, REPROCELL USA

How to culture iPSCs in suspension without agitation
Masashi Iwakami
Nissan Chemical Corporation, Japan

Improving precision medicine with human tissue testing and genomics
David Bunton
CEO REPROCELL Europe (founder of Biopta Ltd. now part of REPROCELL) UK

Bioengineered Human Tissues for Skin, Cancer, and Drug Metabolism
Prof. Stefan Przyborski
CSO, REPROCELL Europe & Professor in Cell Technology, Durham University, UK
Dr. James Shoemaker
CSO, Lena Biosciences, USA

Providing testing solutions for the development of SARS-CoV-2 therapeutics
Prof. Anne Dickinson
Translational and Clinical Research Institute, Faculty of Medical Sciences, University of Newcastle upon Tyne, UK
Dr. Terri Lehman
Chief Technical Officer, REPROCELL Bioserve, USA

How Pharma is using fresh human tissues to better predict drug safety and efficacy
David Bunton
CEO REPROCELL Europe (founder of Biopta Ltd. now part of REPROCELL) UK

Consistent and efficient hPSC culture with a novel animal-origin free culture system
Dr. Hajime Onuki
Ajinomoto Co. Inc.

Providing safety testing solutions for the pharmaceutical and cosmetic industry
Dr. Shaheda Ahmed
Scientific Manager, Alcyomics Ltd. UK

Novel Uses for PCR of iPSCs in Drug Discovery and Cell Biology
Dr. Tsukasa Sugo
CEO and Founder of GenAhead Bio in Fujisawa, Japan

The REPROCELL Biobank: A Unique Tool for Neurodegenerative Disease Research
Dr. Jean Phillipe Richard
Stem Cell Director, REPROCELL USA

The REPROCELL Tissue Network: Facilitating Dermatological Drug Development
Dr. Karen McAuley
Clinical Alliances Manager, REPROCELL Europe
Graeme Macluskie
Director of Precision Medicine, REPROCELL Europe
Human Tissue Testing Videos
Note: Biopta (Glasgow, UK and Maryland, USA) is now REPROCELL’s Center for predictive Drug Discovery.
Alvetex Videos
Note: Reinnervate (Durham, UK) is now part of REPROCELL’s Center for predictive Drug Discovery.